MedTrace Logo

Financial Incentives for Smoking Cessation Treatment Engagement

NCT04601870 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 98

Last updated 2023-01-25

Study results available
· View outcomes & findings →

Summary

This study is being done to see if financial incentives increase the rate at which smokers engage in cessation treatment. A total of 540 participants will be enrolled by invitation from 6 primary care clinics of the participating healthcare system. Participants will be in the study for approximately 28 weeks.

Conditions

  • Quitting Smoking

Interventions

OTHER

No Financial Incentive

No monetary incentive to participate in quit planning and quit counseling with a tobacco cessation specialist.

OTHER

Financial Incentive (100 dollars)

Financial incentive (100 dollars) to participate in quit planning and quit counseling with a tobacco cessation specialist.

OTHER

Financial Incentive (50 dollars)

Financial incentive (50 dollars) to participate in quit planning and quit counseling with a tobacco cessation specialist.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Wisconsin, Madison

    lead OTHER

Principal Investigators

  • Michael C Fiore, MD, MPH, MBA · University of Wisconsin, Madison

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-19
Primary Completion
2021-12-23
Completion
2022-06-17

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04601870 on ClinicalTrials.gov